Search for: "Merck and Co," Results 141 - 160 of 1,277
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Jan 2019, 4:16 am by Edith Roberts
At Reuters, Andrew Chung reports that the justices “appeared sympathetic to Merck & Co in its bid to fend off hundreds of lawsuits accusing the company of failing to adequately warn patients of the risks of thigh bone fractures associated with its osteoporosis drug Fosamax. [read post]
19 Oct 2018, 7:05 am by lbergeson@lawbc.com
., “The eShuttleTM Technology for Propulene Oxide and Reducing CO2 Emissions in the PVC Supply Chain” Greener Synthetic Pathways Award -- Merck & Co. and Merck Research Laboratories, “A Sustainable Commercial Manufacturing Process for Doravirine from Commodity Chemicals” Designing Greener Chemicals Award -- Corteva AgriscienceTM Agriculture Division of DowDuPontTM, “RinskorTM Active -- Improving Rice Production While Reducing… [read post]
11 Oct 2018, 12:57 am by Eszter Szakács
Eszter SzakácsCo-author: Zsolt Lengyel, Danubia Patent and Law Office Just a few months before the CJEU’s judgment in C-121/17 Teva UK Ltd and Others v Gilead Sciences Inc. came out a the Metropolitan Court of Budapest handed down a decision regarding Merck Sharp and Dohme Corp’s (MSD) application for an SPC re the combination of ezetimibe and rosuvastatin. [read post]
7 Sep 2018, 9:37 am by Kang Haggerty & Fetbroyt LLC
” Despite the plaintiff-friendly pleading standards for securities fraud outlined by the Supreme Court in Merck & Co. v. [read post]
21 Aug 2018, 1:18 pm by Adam Harper
A number of lawsuits have recently been filed as a result of injuries associated with the vaccine Zostavax, manufactured by Merck & Co. [read post]
14 Jul 2018, 9:30 pm by Patent Docs
Watson Labs and The Medicines Co. v. [read post]
29 Jun 2018, 3:08 am by Brian Cordery
To recap, what are now known as Arrow declarations originate from the decision in Arrow Generics Ltd & Anor v Merck & Co, Inc [2007] EWHC 1900 (Pat), in which the High Court held that it had the discretion to grant a declaration that a medicinal product was obvious at the priority date. [read post]